Neogen Stock Performance
| NEOG Stock | USD 10.73 0.12 1.13% |
On a scale of 0 to 100, Neogen holds a performance score of 15. The company secures a Beta (Market Risk) of 1.63, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neogen will likely underperform. Please check Neogen's downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Neogen's current price movements will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Neogen are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Neogen reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.13 | Five Day Return 2.78 | Year To Date Return 53.29 | Ten Year Return (40.78) | All Time Return 2.3 K |
Last Split Factor 2:1 | Last Split Date 2021-06-07 |
1 | Disposition of 12912 shares by David Naemura of Neogen at 5.98 subject to Rule 16b-3 | 12/01/2025 |
2 | Neogens Raised Outlook Fuels Turnaround Hopes, Stock Soars | 01/08/2026 |
3 | Neogen Is Up 26.5 percent After Raising 2026 Outlook And Trimming Losses - Has The Bull Case Changed | 01/13/2026 |
4 | Abbott Laboratories Q4 Earnings Report Preview What To Look For | 01/21/2026 |
5 | Acquisition by Nassif Mikheal of tradable shares of Neogen at 9.855 subject to Rule 16b-3 | 01/26/2026 |
6 | ResMed To Report Earnings Tomorrow Here Is What To Expect | 01/28/2026 |
7 | Acquisition by Nassif Mikheal of tradable shares of Neogen at 9.9997 subject to Rule 16b-3 | 02/02/2026 |
8 | Neogen Corporation ABullCase Theory | 02/03/2026 |
9 | Zacks Research Has Negative Estimate for Neogen Q3 Earnings | 02/04/2026 |
10 | How Investors May Respond To Neogen Vet HYCOAT Recall Amid Back-to-Basics Turnaround | 02/06/2026 |
11 | How Recent Earnings And Guidance Are Shaping The Neogen Chemicals Narrative | 02/10/2026 |
| Begin Period Cash Flow | 170.6 M | |
| Total Cashflows From Investing Activities | -99.2 M |
Neogen Relative Risk vs. Return Landscape
If you would invest 637.00 in Neogen on November 13, 2025 and sell it today you would earn a total of 436.00 from holding Neogen or generate 68.45% return on investment over 90 days. Neogen is currently generating 0.9742% in daily expected returns and assumes 4.8352% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Neogen, and 81% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Neogen Target Price Odds to finish over Current Price
The tendency of Neogen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.73 | 90 days | 10.73 | nearly 4.38 |
Based on a normal probability distribution, the odds of Neogen to move above the current price in 90 days from now is nearly 4.38 (This Neogen probability density function shows the probability of Neogen Stock to fall within a particular range of prices over 90 days) .
Neogen Price Density |
| Price |
Predictive Modules for Neogen
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neogen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Neogen Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Neogen is not an exception. The market had few large corrections towards the Neogen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Neogen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Neogen within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.79 | |
β | Beta against Dow Jones | 1.63 | |
σ | Overall volatility | 1.75 | |
Ir | Information ratio | 0.18 |
Neogen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Neogen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Neogen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Neogen appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 894.66 M. Net Loss for the year was (1.09 B) with profit before overhead, payroll, taxes, and interest of 404.77 M. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: How Recent Earnings And Guidance Are Shaping The Neogen Chemicals Narrative |
Neogen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Neogen Stock often depends not only on the future outlook of the current and potential Neogen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neogen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 216.9 M | |
| Cash And Short Term Investments | 129 M |
Neogen Fundamentals Growth
Neogen Stock prices reflect investors' perceptions of the future prospects and financial health of Neogen, and Neogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neogen Stock performance.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0046 | ||||
| Profit Margin | (0.68) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 2.96 B | ||||
| Shares Outstanding | 217.53 M | ||||
| Price To Earning | 13.36 X | ||||
| Price To Book | 1.10 X | ||||
| Price To Sales | 2.62 X | ||||
| Revenue | 894.66 M | ||||
| Gross Profit | 404.77 M | ||||
| EBITDA | (937.75 M) | ||||
| Net Income | (1.09 B) | ||||
| Cash And Equivalents | 347.71 M | ||||
| Cash Per Share | 3.22 X | ||||
| Total Debt | 912.61 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.07 X | ||||
| Book Value Per Share | 9.68 X | ||||
| Cash Flow From Operations | 58.24 M | ||||
| Earnings Per Share | (2.78) X | ||||
| Market Capitalization | 2.31 B | ||||
| Total Asset | 3.44 B | ||||
| Retained Earnings | (536.42 M) | ||||
| Working Capital | 402.93 M | ||||
| Current Asset | 250 M | ||||
| Current Liabilities | 28.6 M | ||||
About Neogen Performance
By analyzing Neogen's fundamental ratios, stakeholders can gain valuable insights into Neogen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Neogen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Neogen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 169.27 | 200.87 | |
| Return On Tangible Assets | (1.30) | (1.23) | |
| Return On Assets | (0.29) | (0.27) | |
| Return On Equity | (0.61) | (0.58) |
Things to note about Neogen performance evaluation
Checking the ongoing alerts about Neogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neogen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Neogen appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 894.66 M. Net Loss for the year was (1.09 B) with profit before overhead, payroll, taxes, and interest of 404.77 M. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: How Recent Earnings And Guidance Are Shaping The Neogen Chemicals Narrative |
- Analyzing Neogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neogen's stock is overvalued or undervalued compared to its peers.
- Examining Neogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neogen's stock. These opinions can provide insight into Neogen's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |